• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Theravance Inc

+ Add to Watchlist

THRX:US

27.9800 USD 0.1700 0.61%

As of 10:34:59 ET on 07/22/2014.

Snapshot for Theravance Inc (THRX)

Open: 27.9000 Day's Range: 27.6800 - 28.1500 Volume: 142,896
Previous Close: 27.8100 52wk Range: 20.2270 - 34.5172 1-Yr Rtn: -9.45%

Stock Chart for THRX

No chart data available.
  • THRX:US 27.9500
  • 1D
  • 1M
  • 1Y
27.8100
Interactive THRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for THRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.8900
Est. EPS (USD) (12/2014) -0.8920
Est. PEG Ratio -
Market Cap (M USD) 3,132.35
Shares Outstanding (M) 112.63
30 Day Average Volume 1,421,892
Price/Book (mrq) 11.9848
Price/Sale (ttm) 815.8492
Dividend Indicated Gross Yield 3.60%
Cash Dividend (USD) 0.2500
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/25/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for THRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for THRX

Theravance Inc., is a biopharmaceutical company. The Company develops small molecule medicines for respiratory disease, bacterial infections, and gastrointestinal disorders.

Rick E WinninghamChairman/President/CEOMichael W AguiarSenior VP/CFO
Bradford J ShaferSenior VP/Secy/Gen CounselLeonard M BlumSenior Vice President
More Company Profile & Key Executives for THRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil